BRONKOSOL Drug Patent Profile
✉ Email this page to a colleague
When do Bronkosol patents expire, and when can generic versions of Bronkosol launch?
Bronkosol is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in BRONKOSOL is isoetharine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the isoetharine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BRONKOSOL?
- What are the global sales for BRONKOSOL?
- What is Average Wholesale Price for BRONKOSOL?
Summary for BRONKOSOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 49 |
| DailyMed Link: | BRONKOSOL at DailyMed |
US Patents and Regulatory Information for BRONKOSOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | BRONKOSOL | isoetharine hydrochloride | SOLUTION;INHALATION | 012339-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanofi Aventis Us | BRONKOSOL | isoetharine hydrochloride | SOLUTION;INHALATION | 012339-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
